Cargando…
Clinical aspects and cytokine response in severe H1N1 influenza A virus infection
INTRODUCTION: The immune responses in patients with novel A(H1N1) virus infection (nvA(H1N1)) are incompletely characterized. We investigated the profile of Th1 and Th17 mediators and interferon-inducible protein-10 (IP-10) in groups with severe and mild nvA(H1N1) disease and correlated them with cl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220006/ https://www.ncbi.nlm.nih.gov/pubmed/21062445 http://dx.doi.org/10.1186/cc9324 |
_version_ | 1782216929337933824 |
---|---|
author | Hagau, Natalia Slavcovici, Adriana Gonganau, Daniel N Oltean, Simona Dirzu, Dan S Brezoszki, Erika S Maxim, Mihaela Ciuce, Constantin Mlesnite, Monica Gavrus, Rodica L Laslo, Carmen Hagau, Radu Petrescu, Magda Studnicska, Daniela M |
author_facet | Hagau, Natalia Slavcovici, Adriana Gonganau, Daniel N Oltean, Simona Dirzu, Dan S Brezoszki, Erika S Maxim, Mihaela Ciuce, Constantin Mlesnite, Monica Gavrus, Rodica L Laslo, Carmen Hagau, Radu Petrescu, Magda Studnicska, Daniela M |
author_sort | Hagau, Natalia |
collection | PubMed |
description | INTRODUCTION: The immune responses in patients with novel A(H1N1) virus infection (nvA(H1N1)) are incompletely characterized. We investigated the profile of Th1 and Th17 mediators and interferon-inducible protein-10 (IP-10) in groups with severe and mild nvA(H1N1) disease and correlated them with clinical aspects. METHODS: Thirty-two patients hospitalized with confirmed nvA(H1N1) infection were enrolled in the study: 21 patients with nvA(H1N1)-acute respiratory distress syndrome (ARDS) and 11 patients with mild disease. One group of 20 patients with bacterial sepsis-ARDS and another group of 15 healthy volunteers were added to compare their cytokine levels with pandemic influenza groups. In the nvA(H1N1)-ARDS group, the serum cytokine samples were obtained on admission and 3 days later. The clinical aspects were recorded prospectively. RESULTS: In the nvA(H1N1)-ARDS group, obesity and lymphocytopenia were more common and IP-10, interleukin (IL)-12, IL-15, tumor necrosis factor (TNF)α, IL-6, IL-8 and IL-9 were significantly increased versus control. When comparing mild with severe nvA(H1N1) groups, IL-6, IL-8, IL-15 and TNFα were significantly higher in the severe group. In nonsurvivors versus survivors, IL-6 and IL-15 were increased on admission and remained higher 3 days later. A positive correlation of IL-6, IL-8 and IL-15 levels with C-reactive protein and with > 5-day interval between symptom onset and admission, and a negative correlation with the PaO(2):FiO(2 )ratio, were found in nvA(H1N1) groups. In obese patients with influenza disease, a significant increased level of IL-8 was found. When comparing viral ARDS with bacterial ARDS, the level of IL-8, IL-17 and TNFα was significantly higher in bacterial ARDS and IL-12 was increased only in viral ARDS. CONCLUSIONS: In our critically ill patients with novel influenza A(H1N1) virus infection, the hallmarks of the severity of disease were IL-6, IL-15, IL-8 and TNFα. These cytokines, except TNFα, had a positive correlation with the admission delay and C-reactive protein, and a negative correlation with the PaO(2):FiO(2 )ratio. Obese patients with nvA(H1N1) disease have a significant level of IL-8. There are significant differences in the level of cytokines when comparing viral ARDS with bacterial ARDS. |
format | Online Article Text |
id | pubmed-3220006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32200062011-11-18 Clinical aspects and cytokine response in severe H1N1 influenza A virus infection Hagau, Natalia Slavcovici, Adriana Gonganau, Daniel N Oltean, Simona Dirzu, Dan S Brezoszki, Erika S Maxim, Mihaela Ciuce, Constantin Mlesnite, Monica Gavrus, Rodica L Laslo, Carmen Hagau, Radu Petrescu, Magda Studnicska, Daniela M Crit Care Research INTRODUCTION: The immune responses in patients with novel A(H1N1) virus infection (nvA(H1N1)) are incompletely characterized. We investigated the profile of Th1 and Th17 mediators and interferon-inducible protein-10 (IP-10) in groups with severe and mild nvA(H1N1) disease and correlated them with clinical aspects. METHODS: Thirty-two patients hospitalized with confirmed nvA(H1N1) infection were enrolled in the study: 21 patients with nvA(H1N1)-acute respiratory distress syndrome (ARDS) and 11 patients with mild disease. One group of 20 patients with bacterial sepsis-ARDS and another group of 15 healthy volunteers were added to compare their cytokine levels with pandemic influenza groups. In the nvA(H1N1)-ARDS group, the serum cytokine samples were obtained on admission and 3 days later. The clinical aspects were recorded prospectively. RESULTS: In the nvA(H1N1)-ARDS group, obesity and lymphocytopenia were more common and IP-10, interleukin (IL)-12, IL-15, tumor necrosis factor (TNF)α, IL-6, IL-8 and IL-9 were significantly increased versus control. When comparing mild with severe nvA(H1N1) groups, IL-6, IL-8, IL-15 and TNFα were significantly higher in the severe group. In nonsurvivors versus survivors, IL-6 and IL-15 were increased on admission and remained higher 3 days later. A positive correlation of IL-6, IL-8 and IL-15 levels with C-reactive protein and with > 5-day interval between symptom onset and admission, and a negative correlation with the PaO(2):FiO(2 )ratio, were found in nvA(H1N1) groups. In obese patients with influenza disease, a significant increased level of IL-8 was found. When comparing viral ARDS with bacterial ARDS, the level of IL-8, IL-17 and TNFα was significantly higher in bacterial ARDS and IL-12 was increased only in viral ARDS. CONCLUSIONS: In our critically ill patients with novel influenza A(H1N1) virus infection, the hallmarks of the severity of disease were IL-6, IL-15, IL-8 and TNFα. These cytokines, except TNFα, had a positive correlation with the admission delay and C-reactive protein, and a negative correlation with the PaO(2):FiO(2 )ratio. Obese patients with nvA(H1N1) disease have a significant level of IL-8. There are significant differences in the level of cytokines when comparing viral ARDS with bacterial ARDS. BioMed Central 2010 2010-11-09 /pmc/articles/PMC3220006/ /pubmed/21062445 http://dx.doi.org/10.1186/cc9324 Text en Copyright ©2010 Hagau et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hagau, Natalia Slavcovici, Adriana Gonganau, Daniel N Oltean, Simona Dirzu, Dan S Brezoszki, Erika S Maxim, Mihaela Ciuce, Constantin Mlesnite, Monica Gavrus, Rodica L Laslo, Carmen Hagau, Radu Petrescu, Magda Studnicska, Daniela M Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title | Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title_full | Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title_fullStr | Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title_full_unstemmed | Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title_short | Clinical aspects and cytokine response in severe H1N1 influenza A virus infection |
title_sort | clinical aspects and cytokine response in severe h1n1 influenza a virus infection |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220006/ https://www.ncbi.nlm.nih.gov/pubmed/21062445 http://dx.doi.org/10.1186/cc9324 |
work_keys_str_mv | AT hagaunatalia clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT slavcoviciadriana clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT gonganaudanieln clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT olteansimona clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT dirzudans clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT brezoszkierikas clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT maximmihaela clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT ciuceconstantin clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT mlesnitemonica clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT gavrusrodical clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT laslocarmen clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT hagauradu clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT petrescumagda clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection AT studnicskadanielam clinicalaspectsandcytokineresponseinsevereh1n1influenzaavirusinfection |